Grayscale Zcash Trust: The Discount That Won't Die

The data is clear: Grayscale Zcash Trust (ZCSH) has traded at a discount to its net asset value for 700 of the last 800 days. The maximum discount hit 55% in October 2022. Yet the market is buzzing over the latest filing to list the trust on NYSE Arca. The narrative is that listing will close the discount, just like GBTC's conversion to an ETF. The data shows a different story — one of structural mispricing, not a simple arbitrage opportunity. Let me set the context. The Grayscale Zcash Trust holds approximately 2.3% of all circulating ZEC, valued at $155 million. It is a closed-end fund, meaning shares cannot be created or redeemed. The only way to get exposure to ZEC via the trust is to buy shares on the secondary market. Digital Currency Group (DCG) controls the trust, and they also control Foundry, which operates a mining pool with 15.4% of Zcash's hashrate. The conflict of interest is explicit in the filing: DCG can prioritize its own interests over those of trust shareholders. The trust also has a history of premium spikes — a 240% premium in 2020 — and deep discounts. The current discount is 7%. Now the core analysis. Discounts in closed-end funds typically reflect the cost of holding illiquid assets with no redemption mechanism. For ZEC, the liquidity is thin. But the structural issue here is DCG's control. In any normal market, a discount would attract arbitrageurs who buy the trust and sell the underlying asset. But that's impossible because the trust is a closed-end fund. The only way to profit from the discount is to short the trust and buy ZEC, but that requires a borrow market that doesn't exist for ZCSH. The discount is a structural risk premium, not a market inefficiency. I've seen this pattern before. In 2020, during DeFi Summer, I audited a liquidity pool that promised yield farming returns but had a centralized admin key. The smart contract executed logic, but the admin could drain the pool at any time. The code did not lie, but the audit did — it ignored the centralization risk. The same applies here. The trust's filings detail the conflict, but the market is pricing it as a non-issue. The discount is a signal that the market already knows the price of DCG's control. The question is: will listing on NYSE Arca reduce that risk? The answer is no. Listing the trust on a national exchange does not change the governance structure. DCG still holds the majority of voting power. They can still decide to sell the underlying ZEC, dilute shareholders, or use the trust to fund their mining operations. The data shows that the discount has persisted through multiple listing attempts. In 2021, when the trust moved to OTCQX, the discount narrowed temporarily but then widened again. The smart money is not buying the convergence narrative. Here is the contrarian angle. The market expects the NYSE Arca listing to close the discount, similar to how GBTC's discount collapsed after the ETF approval. But GBTC had a different structure: it was a trust that could convert to an ETF, allowing creation/redemption. ZCSH has no conversion mechanism. The trust is a closed-end fund forever. The only way to close the discount is for DCG to voluntarily buy back shares or convert the trust to an open-end structure. Neither is happening. The filing is a marketing move. The real risk is that DCG uses the listing to dump shares to retail investors at a discount, while they hedge their ZEC holdings through the mining pool. I've been in this industry for 21 years. I've seen what happens when insiders control both the asset and the vehicle. In 2017, I manually reviewed smart contracts for ICOs. I found a re-entrancy bug that would have allowed the team to drain funds. The code did not lie, only the audit did. Trust is a technical variable, not a marketing claim. Here, the trust's filings are the audit. They tell you the risk. The question is whether you are paying attention. The takeaway is straightforward. Don't buy the discount convergence story. The trust is a governance trap. Until DCG's control is broken or the trust is restructured, the discount will persist. If you want ZEC exposure, buy the asset directly. The trust is a tax-inefficient wrapper for a conflict of interest. The data shows that the discount is a feature, not a bug. The code does not lie, only the audits do. And here, the audit is the trust's own filings.